APTO
Aptose Biosciences Inc
NASDAQ: APTO · HEALTHCARE · BIOTECHNOLOGY
$1.71
+0.00% today
Updated 2026-04-30
Market cap
$4.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-36.38
Dividend yield
—
52W range
$0 – $0
Volume
—
Aptose Biosciences Inc (APTO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-694.00%
ROA
-142.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2005 | $4998.00 | $-17.58M | 79.99% | -348,552.68% | -351,773.17% |
| 2006 | $6.00 | $-16.27M | -49,883.33% | -251,439,950.00% | -271,114,333.33% |
| 2007 | $100023.00 | $-9.02M | 84.00% | -7,624.01% | -9,012.99% |
| 2008 | $43023.00 | $-6.37M | 95.32% | -25,644.16% | -14,815.70% |
| 2009 | $168807.00 | $-8.09M | 100.00% | -3,894.57% | -4,789.74% |
| 2010 | $124156.00 | $5.08M | 100.00% | -4,283.99% | 4,091.86% |
| 2011 | $57800.00 | $-5.16M | — | -8,821.87% | -8,919.72% |
| 2012 | $42479.00 | $-4.48M | — | -10,508.58% | -10,540.56% |
| 2013 | $0.00 | $-5.40M | — | — | — |
| 2014 | $0.00 | $-11503.00 | — | — | — |
| 2015 | $0.00 | $-10.54M | — | — | — |
| 2016 | $0.00 | $-13.86M | — | — | — |
| 2017 | $0.00 | $-11.66M | — | — | — |
| 2018 | $0.00 | $-28.87M | — | — | — |
| 2019 | $0.00 | $-26.28M | — | — | — |
| 2020 | $0.00 | $-55.24M | — | — | — |
| 2021 | $0.00 | $-65.35M | — | — | — |
| 2022 | $0.00 | $-41.82M | — | — | — |
| 2023 | $0.00 | $-51.21M | — | — | — |
| 2024 | $0.00 | $-25.43M | — | — | — |